Ocular Therapeutix Inc
OCULHealthcare|Biotechnology|USA
$10.21
-0.34 (-3.27%)
Tangible Book
$2.66
About
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Stock Price
-7.8%(1Y)
Pipeline Summary
58 total trials7
Phase 1
9
Phase 2
15
Phase 3
24
Phase 4
Completed: 34Terminated: 7Active: 2Recruiting: 4Withdrawn: 3Unknown: 8
Active Trials (6)
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration
NCT06495918Neovascular Age-related Macular Degeneration
Phase 3Active
Enrollment: 825 participants
Dextenza in the Post-op Management of Vitreoretinal Surgeries
NCT04371445Vitreoretinal Surgery
Phase 4Recruiting
Enrollment: 30 participants
A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy
NCT07235085Non-Proliferative Diabetic Retinopathy
Phase 3Recruiting
Enrollment: 930 participants
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration
NCT06223958Neovascular Age-Related Macular Degeneration
Phase 3Active
Enrollment: 344 participants
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
NCT07516132Neovascular Age-Related Macular Degeneration (nAMD)
Phase 3Recruiting
Enrollment: 850 participants
BioScore
5.5/10
Watchlist
Ownership
Recent Insider Trades
Waheed NadiaSELL
2026-06-0314,828 shares @ $8.27
Dugel PravinSELL
2026-05-2621,156 shares @ $8.2
Kaiser PeterSELL
2026-05-262,967 shares @ $8.2
Heier Jeffrey S.SELL
2026-05-263,018 shares @ $8.2
Nayak SanjaySELL
2026-05-261,858 shares @ $8.2
Recent News
2026-06-25 14:05:26
2026-06-18 16:35:19
2026-06-18 13:39:02
2026-06-18 00:00:12
2026-06-17 14:56:28
Data last updated: Jul 13, 2026, 12:43 PM